Federated Kaufmann Fund specializes in the fields of mutual funds, managed accounts institutional, and separate accounts.
Business Model:
Revenue: $1.4B
Employees: 1,001-5,000
Address: 1001 Liberty Avenue
City: Pittsburgh
State: PA
Zip: 15222-3779
Country: US
Federated Kaufmann Fund is an investment management firm that specializes in the fields of mutual funds, managed accounts institutional, and separate accounts. IT offers equity, international, fixed income, alternative, and money market strategies.
Contact Phone:
+14122881900
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2021 | WM Technology | PIPE | 325M |
5/2002 | Onyx Pharmaceuticals | Venture Round | 20M |
6/2021 | BarkBox | Post-IPO Equity | 0 |
11/2021 | Regulus Therapeutics | Private Placement | 34.6M |
7/2020 | Frequency Therapeutics | Post-IPO Equity | 42.3M |
4/2023 | Regulus Therapeutics | Post-IPO Equity | 0 |
10/2020 | Fisker | Post-IPO Equity | 0 |
10/2009 | Threshold Pharmaceuticals | Post-IPO Equity | 35M |
3/2021 | Paysafe | Post-IPO Equity | 0 |
3/2021 | Century Therapeutics | Series C | 0 |
5/2007 | Spectrum Pharmaceuticals | Post-IPO Equity | 0 |
2/2006 | Insulet Corporation | Series E | 0 |
3/2021 | Graphite Bio | Series B | 150.7M |
7/2021 | Hyzon Motors | Post-IPO Equity | 0 |
5/2021 | Blue Owl | Post-IPO Equity | 0 |
7/2021 | AvePoint | Post-IPO Equity | 140M |
2/2014 | BioDelivery Sciences | Post-IPO Equity | 60M |
5/2021 | NeoGenomics | Post-IPO Equity | 0 |
6/2021 | Talkspace | Post-IPO Equity | 0 |
6/2002 | Dexcom | Series C | 0 |
7/2020 | Molecular Partners | Post-IPO Equity | 0 |
9/2021 | Archer | Post-IPO Equity | 0 |
6/2021 | Taboola | Post-IPO Equity | 0 |
1/2006 | Cytokinetics | Post-IPO Equity | 33M |
10/2020 | Rezolute | Post-IPO Equity | 41M |
4/2021 | CeQur SA | Series C | 0 |
10/2020 | Lordstown Motors | Post-IPO Equity | 500M |
9/2021 | Jasper Therapeutics | Post-IPO Equity | 0 |
8/2021 | Laronde | Series B | 440M |
11/2021 | Regulus Therapeutics | Post-IPO Equity | 0 |
9/2021 | Jasper Therapeutics | Post-IPO Equity | 0 |
9/2021 | Archer | Post-IPO Equity | 0 |
8/2021 | Laronde | Series B | 0 |
7/2021 | Hyzon Motors | Post-IPO Equity | 0 |
7/2021 | AvePoint | Post-IPO Equity | 0 |
6/2021 | Taboola | Post-IPO Equity | 0 |
6/2021 | Talkspace | Post-IPO Equity | 0 |
6/2021 | WM Technology | Post-IPO Equity | 0 |
6/2021 | BarkBox | Post-IPO Equity | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|